DK1781697T3 - Nyt carbamyleret erythropoietinprotein samt fremstillingsmetode - Google Patents
Nyt carbamyleret erythropoietinprotein samt fremstillingsmetodeInfo
- Publication number
- DK1781697T3 DK1781697T3 DK05755533T DK05755533T DK1781697T3 DK 1781697 T3 DK1781697 T3 DK 1781697T3 DK 05755533 T DK05755533 T DK 05755533T DK 05755533 T DK05755533 T DK 05755533T DK 1781697 T3 DK1781697 T3 DK 1781697T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- new
- well
- carbamylated erythropoietin
- erythropoietin protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58637004P | 2004-07-07 | 2004-07-07 | |
DKPA200401075 | 2004-07-07 | ||
US69387005P | 2005-06-23 | 2005-06-23 | |
PCT/DK2005/000477 WO2006002646A2 (en) | 2004-07-07 | 2005-07-07 | Novel carbamylated epo and method for its production |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1781697T3 true DK1781697T3 (da) | 2009-07-06 |
Family
ID=34979159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05755533T DK1781697T3 (da) | 2004-07-07 | 2005-07-07 | Nyt carbamyleret erythropoietinprotein samt fremstillingsmetode |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1781697B1 (es) |
JP (1) | JP5025470B2 (es) |
AT (1) | ATE429444T1 (es) |
AU (1) | AU2005259689B2 (es) |
BR (1) | BRPI0513029A (es) |
CA (1) | CA2572643A1 (es) |
CY (1) | CY1109232T1 (es) |
DE (1) | DE602005014117D1 (es) |
DK (1) | DK1781697T3 (es) |
EA (1) | EA011586B1 (es) |
ES (1) | ES2325034T3 (es) |
HK (1) | HK1109631A1 (es) |
HR (1) | HRP20090343T1 (es) |
IL (1) | IL180518A0 (es) |
MX (1) | MXPA06014742A (es) |
NO (1) | NO20070687L (es) |
PL (1) | PL1781697T3 (es) |
PT (1) | PT1781697E (es) |
SI (1) | SI1781697T1 (es) |
WO (1) | WO2006002646A2 (es) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7718363B2 (en) | 2003-04-25 | 2010-05-18 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
EP1771190A4 (en) * | 2004-07-02 | 2009-07-22 | Kenneth S Warren Inst Inc | METHOD FOR THE PRODUCTION OF COMPLETELY CARBAMYLATED ERYTHROPOIETIN |
DE102006004008A1 (de) * | 2006-01-27 | 2007-08-02 | Hannelore Prof. Dr. Dr. Ehrenreich | Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose |
US7811560B2 (en) * | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
EP1961821B1 (en) | 2007-02-22 | 2009-06-10 | Polymun Scientific Immunbiologische Forschung GmbH | Erythropoietin fusion protein |
AR065613A1 (es) * | 2007-03-09 | 2009-06-17 | Chugai Pharmaceutical Co Ltd | Agentes de proteccion para organos transplantados |
ES2750254T3 (es) | 2007-09-27 | 2020-03-25 | Amgen Inc | Formulaciones farmacéuticas |
ES2962777T3 (es) | 2007-11-15 | 2024-03-21 | Amgen Inc | Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral |
AU2009206306B2 (en) | 2008-01-25 | 2013-06-06 | Amgen Inc. | Ferroportin antibodies and methods of use |
CA2722600C (en) | 2008-05-01 | 2014-01-21 | Amgen Inc. | Anti-hepcidin antibodies and methods of use |
JP5694171B2 (ja) | 2008-09-26 | 2015-04-01 | アンブルックス, インコーポレイテッドAmbrx, Inc. | 修飾されている動物のエリスロポエチンポリペプチドおよびそれらの使用 |
EP2349332B1 (en) | 2008-11-13 | 2019-10-23 | The General Hospital Corporation | Methods and compositions for regulating iron homeostasis by modulation bmp-6 |
US9662271B2 (en) | 2009-10-23 | 2017-05-30 | Amgen Inc. | Vial adapter and system |
TW201129374A (en) | 2009-10-26 | 2011-09-01 | Lundbeck & Co As H | Use of carbamylated erythropoietin for the treatment of Friedreich's ataxia |
TW201129375A (en) | 2009-11-18 | 2011-09-01 | Lundbeck & Co As H | Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin |
MX2012014180A (es) | 2010-06-07 | 2013-05-06 | Amgen Inc | Dispositivo de administracion de farmacos. |
TW201213807A (en) | 2010-07-19 | 2012-04-01 | Lundbeck & Co As H | Bioassay for the measurement of CEPO concentration and activity |
WO2012069474A2 (en) | 2010-11-24 | 2012-05-31 | H. Lundbeck A/S | A method for reducing potential virus burden in a sample by cyanate treatment |
MX341790B (es) | 2011-03-31 | 2016-09-02 | Amgen Inc | Adaptador de viales y sistema. |
EP3498323B1 (en) | 2011-04-20 | 2022-07-13 | Amgen Inc. | Autoinjector apparatus |
CA3175560A1 (en) | 2011-10-14 | 2013-04-18 | Amgen Inc. | Injector and method of assembly |
PT2802652T (pt) | 2012-01-12 | 2019-09-10 | Endo Global Ventures | Enzimas de clostridium histolyticum |
ES2951440T3 (es) | 2012-11-21 | 2023-10-20 | Amgen Inc | Dispositivo de administración de fármacos |
CA2904725C (en) | 2013-03-15 | 2022-04-12 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
BR112015022123B1 (pt) | 2013-03-15 | 2022-08-09 | Intrinsic Lifesciences, Llc | Anticorpos, fragmentos de ligação ao antígeno dos mesmos que se ligam especificamente à hepcidina ou um peptídeo de hepcidina, uso, meio contentor e kit |
US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
EP2976117B1 (en) | 2013-03-22 | 2020-12-30 | Amgen Inc. | Injector and method of assembly |
CA3168888A1 (en) | 2013-10-24 | 2015-04-30 | Amgen Inc. | Drug delivery system with temperature-sensitive control |
CA2920894C (en) | 2013-10-24 | 2023-03-14 | Amgen Inc. | Injector and method of assembly |
US10994112B2 (en) | 2014-02-05 | 2021-05-04 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
JP6640113B2 (ja) | 2014-05-07 | 2020-02-05 | アムジエン・インコーポレーテツド | 衝撃低減要素を有する自動注入器 |
SG11201609970VA (en) | 2014-06-03 | 2016-12-29 | Amgen Inc | Systems and methods for remotely processing data collected by a drug delivery device |
NZ730186A (en) | 2014-09-22 | 2020-04-24 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
EP3943135A3 (en) | 2014-10-14 | 2022-06-29 | Amgen Inc. | Drug injection device with visual and audible indicators |
ES2785311T3 (es) | 2014-12-19 | 2020-10-06 | Amgen Inc | Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario |
JP6716566B2 (ja) | 2014-12-19 | 2020-07-01 | アムジエン・インコーポレーテツド | 近接センサ付き薬物送達装置 |
ES2748750T3 (es) | 2015-02-17 | 2020-03-17 | Amgen Inc | Dispositivo de administración de fármacos con sujeción asistida por vacío y/o realimentación |
WO2016138434A1 (en) | 2015-02-27 | 2016-09-01 | Amgen Inc. | Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement |
WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
US11351308B2 (en) | 2015-12-09 | 2022-06-07 | Amgen Inc. | Auto-injector with signaling cap |
US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
WO2017160799A1 (en) | 2016-03-15 | 2017-09-21 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
WO2017189089A1 (en) | 2016-04-29 | 2017-11-02 | Amgen Inc. | Drug delivery device with messaging label |
WO2017192287A1 (en) | 2016-05-02 | 2017-11-09 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
AU2017263558B2 (en) | 2016-05-13 | 2022-12-22 | Amgen Inc. | Vial sleeve assembly |
WO2017200989A1 (en) | 2016-05-16 | 2017-11-23 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
EP3465124A1 (en) | 2016-06-03 | 2019-04-10 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
WO2018004842A1 (en) | 2016-07-01 | 2018-01-04 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
WO2018034784A1 (en) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Drug delivery device with placement detection |
EP3532127A1 (en) | 2016-10-25 | 2019-09-04 | Amgen Inc. | On-body injector |
CA3049780A1 (en) | 2017-01-17 | 2018-07-26 | Amgen Inc. | Injection devices and related methods of use and assembly |
AU2018221351B2 (en) | 2017-02-17 | 2023-02-23 | Amgen Inc. | Insertion mechanism for drug delivery device |
US11752258B2 (en) | 2017-02-17 | 2023-09-12 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
CN115969318A (zh) | 2017-03-01 | 2023-04-18 | 恩多风投有限公司 | 用于评估和治疗橘皮组织的装置和方法 |
CA3050927A1 (en) | 2017-03-06 | 2018-09-13 | Brian Stonecipher | Drug delivery device with activation prevention feature |
IL268478B2 (en) | 2017-03-07 | 2023-10-01 | Amgen Inc | Inserting a needle using super pressure |
IL268386B2 (en) | 2017-03-09 | 2023-11-01 | Amgen Inc | Insertion mechanism for a drug delivery device |
WO2018172219A1 (en) | 2017-03-20 | 2018-09-27 | F. Hoffmann-La Roche Ag | Method for in vitro glycoengineering of an erythropoiesis stimulating protein |
KR20240001279A (ko) | 2017-03-28 | 2024-01-03 | 엔도 벤쳐즈 리미티드 | 개선된 콜라게나제 생성 방법 |
US11957883B2 (en) | 2017-03-28 | 2024-04-16 | Amgen Inc. | Plunger rod and syringe assembly system and method |
US11590294B2 (en) | 2017-06-08 | 2023-02-28 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
WO2018226565A1 (en) | 2017-06-08 | 2018-12-13 | Amgen Inc. | Torque driven drug delivery device |
MX2019015472A (es) | 2017-06-22 | 2020-02-19 | Amgen Inc | Reduccion del impacto/choque de la activacion del mecanismo. |
JP7475860B2 (ja) | 2017-06-23 | 2024-04-30 | アムジエン・インコーポレーテツド | スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス |
EP3651832B1 (en) | 2017-07-14 | 2023-12-13 | Amgen Inc. | Needle insertion-retraction system having dual torsion spring system |
IL271173B2 (en) | 2017-07-21 | 2024-04-01 | Amgen Inc | Gas permeable sealing element for drug container and methods of assembly |
WO2019022951A1 (en) | 2017-07-25 | 2019-01-31 | Amgen Inc. | DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF |
WO2019022950A1 (en) | 2017-07-25 | 2019-01-31 | Amgen Inc. | DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF |
WO2019032482A2 (en) | 2017-08-09 | 2019-02-14 | Amgen Inc. | HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM |
US11077246B2 (en) | 2017-08-18 | 2021-08-03 | Amgen Inc. | Wearable injector with sterile adhesive patch |
US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
ES2939292T3 (es) | 2017-10-04 | 2023-04-20 | Amgen Inc | Adaptador de flujo para dispositivo de administración de fármacos |
EP3691716B1 (en) | 2017-10-06 | 2023-11-29 | Amgen Inc. | Drug delivery device with interlock assembly and related method of assembly |
IL273323B1 (en) | 2017-10-09 | 2024-06-01 | Amgen Inc | Drug delivery device with drive assembly and related assembly method |
US11826480B2 (en) | 2017-11-03 | 2023-11-28 | Amgen Inc. | Systems and approaches for sterilizing a drug delivery device |
WO2019089178A1 (en) | 2017-11-06 | 2019-05-09 | Amgen Inc. | Drug delivery device with placement and flow sensing |
US20200338271A1 (en) | 2017-11-06 | 2020-10-29 | Amgen Inc. | Fill-finish assemblies and related methods |
MA50557A (fr) | 2017-11-10 | 2020-09-16 | Amgen Inc | Pistons pour dispositifs d'administration de médicament |
MX2020005066A (es) | 2017-11-16 | 2020-08-20 | Amgen Inc | Autoinyector con deteccion de detencion y punto final. |
MA50904A (fr) | 2017-11-16 | 2020-09-23 | Amgen Inc | Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament |
US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
MX2021000749A (es) | 2018-07-24 | 2021-03-29 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
WO2020023444A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Delivery devices for administering drugs |
WO2020023336A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
WO2020023220A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation |
WO2020028009A1 (en) | 2018-07-31 | 2020-02-06 | Amgen Inc. | Fluid path assembly for a drug delivery device |
CA3106452A1 (en) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Interventional dosing systems and methods |
IL281469B1 (en) | 2018-09-28 | 2024-04-01 | Amgen Inc | Assembling a memory alloy ejector activation assembly for a drug delivery device |
WO2020072577A1 (en) | 2018-10-02 | 2020-04-09 | Amgen Inc. | Injection systems for drug delivery with internal force transmission |
AR116607A1 (es) | 2018-10-05 | 2021-05-26 | Amgen Inc | Dispositivo de administración de fármacos con indicador de dosis |
CN112689523A (zh) | 2018-10-15 | 2021-04-20 | 安进公司 | 用于药物递送装置的平台组装方法 |
EP3866890A1 (en) | 2018-10-15 | 2021-08-25 | Amgen Inc. | Drug delivery device having damping mechanism |
EP3873566A1 (en) | 2018-11-01 | 2021-09-08 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
CA3113076A1 (en) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
CA3137360A1 (en) | 2019-04-24 | 2020-10-29 | Amgen Inc. | Syringe sterilization verification assemblies and methods |
EP4017560A2 (en) | 2019-08-23 | 2022-06-29 | Amgen, Inc | Drug delivery device with configurable needle shield engagement components and related methods |
RU2720103C1 (ru) * | 2019-10-16 | 2020-04-24 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ коррекции нарушений микроциркуляции в плаценте карбамилированным дарбэпоэтином при ADMA-подобной модели преэклампсии |
AU2022279223A1 (en) | 2021-05-21 | 2023-10-19 | Amgen Inc. | Method of optimizing a filling recipe for a drug container |
WO2024094457A1 (en) | 2022-11-02 | 2024-05-10 | F. Hoffmann-La Roche Ag | Method for producing glycoprotein compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2215748C2 (ru) * | 1999-04-09 | 2003-11-10 | Сентро Де Инмунология Молекулар | Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция |
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
PA8536201A1 (es) * | 2000-12-29 | 2002-08-29 | Kenneth S Warren Inst Inc | Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina |
CA2526096A1 (en) * | 2003-05-19 | 2004-12-29 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window |
-
2005
- 2005-07-07 BR BRPI0513029-8A patent/BRPI0513029A/pt not_active IP Right Cessation
- 2005-07-07 SI SI200530707T patent/SI1781697T1/sl unknown
- 2005-07-07 DK DK05755533T patent/DK1781697T3/da active
- 2005-07-07 EA EA200700255A patent/EA011586B1/ru not_active IP Right Cessation
- 2005-07-07 DE DE602005014117T patent/DE602005014117D1/de active Active
- 2005-07-07 EP EP05755533A patent/EP1781697B1/en active Active
- 2005-07-07 AU AU2005259689A patent/AU2005259689B2/en not_active Ceased
- 2005-07-07 WO PCT/DK2005/000477 patent/WO2006002646A2/en active Application Filing
- 2005-07-07 ES ES05755533T patent/ES2325034T3/es active Active
- 2005-07-07 PL PL05755533T patent/PL1781697T3/pl unknown
- 2005-07-07 JP JP2007519619A patent/JP5025470B2/ja not_active Expired - Fee Related
- 2005-07-07 CA CA002572643A patent/CA2572643A1/en not_active Abandoned
- 2005-07-07 AT AT05755533T patent/ATE429444T1/de active
- 2005-07-07 PT PT05755533T patent/PT1781697E/pt unknown
- 2005-07-07 MX MXPA06014742A patent/MXPA06014742A/es active IP Right Grant
-
2007
- 2007-01-02 IL IL180518A patent/IL180518A0/en unknown
- 2007-02-06 NO NO20070687A patent/NO20070687L/no not_active Application Discontinuation
-
2008
- 2008-01-10 HK HK08100325.8A patent/HK1109631A1/xx not_active IP Right Cessation
-
2009
- 2009-06-15 HR HR20090343T patent/HRP20090343T1/xx unknown
- 2009-07-14 CY CY20091100734T patent/CY1109232T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL1781697T3 (pl) | 2009-10-30 |
MXPA06014742A (es) | 2007-02-16 |
WO2006002646A3 (en) | 2006-04-13 |
HK1109631A1 (en) | 2008-06-13 |
WO2006002646A2 (en) | 2006-01-12 |
PT1781697E (pt) | 2009-06-25 |
DE602005014117D1 (de) | 2009-06-04 |
EA011586B1 (ru) | 2009-04-28 |
IL180518A0 (en) | 2007-06-03 |
AU2005259689B2 (en) | 2011-10-06 |
JP5025470B2 (ja) | 2012-09-12 |
BRPI0513029A (pt) | 2008-04-22 |
ES2325034T3 (es) | 2009-08-24 |
SI1781697T1 (sl) | 2009-08-31 |
EA200700255A1 (ru) | 2007-06-29 |
CA2572643A1 (en) | 2006-01-12 |
EP1781697B1 (en) | 2009-04-22 |
ATE429444T1 (de) | 2009-05-15 |
NO20070687L (no) | 2007-03-27 |
AU2005259689A1 (en) | 2006-01-12 |
EP1781697A2 (en) | 2007-05-09 |
JP2008505133A (ja) | 2008-02-21 |
CY1109232T1 (el) | 2014-07-02 |
HRP20090343T1 (en) | 2009-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1781697T3 (da) | Nyt carbamyleret erythropoietinprotein samt fremstillingsmetode | |
EA200701528A1 (ru) | Новые нутрицевтические композиции | |
BRPI0508610A (pt) | derivados de aminoácidos | |
SE0301372D0 (sv) | Novel compounds | |
EP2202310A3 (en) | Caustic stable chromatography ligands | |
MY151036A (en) | Synthesis of (r)-n-methylnaltrexone | |
CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
ATE497492T1 (de) | Reinigung von montelukast | |
TW200603798A (en) | Disalt inhibitors of il-12 production | |
ATE536859T1 (de) | Maca-extrakt und diesen extrakt enthaltende kosmetische zusammensetzung | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
WO2004033659A3 (en) | Novel tumor suppressor gene and compositions and methods for making and using the same | |
ATE501268T1 (de) | Vorrichtungen und verfahren zur bestimmung von proteaseaktivität | |
IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
DE50305507D1 (de) | Zusammensetzungen zur herstellung von aminoplasterzeugnissen | |
EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением | |
EA200401289A1 (ru) | Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения | |
DE502004009136D1 (de) | NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb | |
EA200870236A1 (ru) | Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе | |
TW200612979A (en) | Novel carbamylated epo and method for its production | |
UA91983C2 (ru) | Новый карбамилированный эритропоэтин и способ его получения | |
ATE482182T1 (de) | Asymmetrische hydrierung zur herstellung von diphenylalaninderivaten | |
EA200800392A1 (ru) | Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат | |
MY142798A (en) | Methods for preventing glyconoylation of proteins | |
DE602005009509D1 (de) | Expression von nitrilhydratasen in einem zweivektorexpressionssystem |